The labels for Zepbound, Mounjaro, Ozempic and Wegovy all name the same three areas, the abdomen, thigh and upper arm, and all say to change the injection site rather than using the same spot each time.[1][2][3][4] Zepbound, Mounjaro and Wegovy say to rotate sites with each dose; Ozempic says to use a different site each week within the same region.

This page only reports what the prescribing information and Instructions for Use say, read on DailyMed on 20 November 2026. Your prescriber or pharmacist can show you where and how to inject.

What the labels say, side by side

Section 2 of each prescribing information covers administration:

LabelAreas named in section 2Rotation wording in section 2
Zepbound[1]“the abdomen, thigh, or another person should inject in the back of the upper arm”“Rotate injection sites with each dose.”
Mounjaro[2]“the abdomen, thigh, or have another person inject MOUNJARO in the back of the upper arm”“Rotate injection sites with each dose.”
Ozempic[3]“the abdomen, thigh, or upper arm”“Instruct patients to use a different injection site each week when injecting in the same body region.”
Wegovy[4]“the abdomen, thigh, or upper arm”“Rotate injection sites with each dose.”

The Wegovy label adds that “The time of day and the injection site can be changed without the need for a dosage modification.”[4]

What the Instructions for Use add

The patient Instructions for Use go into more detail. The wording differs by device, so it is quoted here by product.

Zepbound and Mounjaro, pens and KwikPens. “Change (rotate) your injection site each week. You may use the same area of your body but be sure to choose a different injection site in that area.” The KwikPen instructions place stomach injections “at least 2 inches from the belly button”.[1][2]

Zepbound and Mounjaro, vials. “Change (rotate) your injection site within the area you choose for each dose to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.” They continue: “Do not inject where the skin has pits, is thickened, or has lumps. Do not inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin.”[1][2]

Zepbound and Mounjaro with other injections. The vial instructions say not to inject in “the same injection site used for other medicines”.[1] The Mounjaro patient information says insulin and Mounjaro may go in the same body area “but not right next to each other”.[2]

Ozempic and Wegovy, single-dose syringes. Inject into the stomach area “at least 2 inches from the belly button”, the thighs, or the back of the upper arm “only with help from someone else”, and “Avoid using the exact same spot as the last time between injections.”[3][4]

Wegovy pens. “Do not inject into an area where the skin is tender, bruised, red, or hard.” The FlexTouch instructions say: “You may inject in the same body area each week, but make sure it is not in the same spot used for the last injection.”[4]

Several of the Instructions for Use also say that your healthcare provider can help you choose the injection site that is best for you.

Compounds without a label

For compounds with no approved label, there are no Instructions for Use to quote. The compound calculators cover only the arithmetic. For where and how to inject, follow your prescriber’s or pharmacy’s instructions.

Keeping a record of sites

The instructions above all depend on knowing where the last injection went. A short note at the time is enough: “left abdomen”, “right thigh”. The printable dose log has a site column, written in your own words, next to the date, time and dose, so the last site is on the same line as the last dose.

Where Kept fits

Kept has no injection-site feature and no site map. What Kept, a paid iPhone app, does is the part around the injection: a reminder when each dose is due, Log, Skip or Snooze straight from the notification, and a history of every dose you have logged. If you want to track sites as well, use the paper log alongside it.

For the dose amounts and schedules each label sets out, see the Zepbound, Mounjaro, Ozempic and Wegovy pages.

Ozempic, Wegovy and FlexTouch are registered trademarks of Novo Nordisk A/S. Mounjaro, Zepbound and KwikPen are registered trademarks of Eli Lilly and Company. Kept is independent and not affiliated with, endorsed by or sponsored by Novo Nordisk A/S or Eli Lilly and Company.